Skip to content

Study Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG

Randomized Controlled Trial Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04652336
Enrollment
100
Registered
2020-12-03
Start date
2020-12-10
Completion date
2021-12-10
Last updated
2020-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GERD

Keywords

de Novo GERD

Brief summary

The aim of this study is to investigate the effect of ligamentum teres cardiopexy on incidence of de Novo GERD.

Detailed description

Laparoscopic Sleeve Gastrectomy (LSG) is now the most commonly performed bariatric surgery world wide. The results of LSG on outcomes of GERD are conflicting. It has been reported to increase the severity of pre existing GERD and also to cause new onset GERD in considerable number of patients. In this study the effect of adding a novel procedure i.e. ligamentum teres cardiopexy,(LTC) to regular LSG on occurence of de Novo GERD will be investigated. de Novo GERD has been found to occur in 20% of cases post LSG. This study is a randomized, prospective, parallel group, controlled trial to compare the effect of LSG versus LSG with LTC on occurence of de Novo GERD. This is a single center based trial, being conducted in GEM hospital and research center, Coimbatore, Tamil Nadu, India. The trial has been approved by GEM research ethics committee. Investigators are planning to enroll patients who are not having any objective or subjective evidence of GERD. The participants will be optimized as per institutional bariatric surgery protocol. After complete evaluation and optimization, participants will be randomized by computer generated random numbers into either LSG or LSG with LTC group. The demographic data, preoperative GERD - Q scores, 24 hour pH study, intra operative details will be recorded. Post operative details during each follow up will be recorded, which will include excess weight loss, GERD - Q scores. At 6 months follow up repeat 24 hour pH study will be done to assess the status of GERD objectively. The trial duration is expected to be of 1 year where in investigators will be recruiting patients for 6 months.

Interventions

PROCEDURElaparoscopic sleeve gastrectomy

Comparator arm - will receive standard laparoscopic sleeve gastrectomy

PROCEDUREligamentum teres cardiopexy with sleeve gastrectomy

experimental arm - Ligamentum teres will be divided from umbilicus to up to umbilical fissure. The ligament will then be wrapped around lower esophagus and sutured.

Sponsors

GEM Hospital & Research Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* candidate for bariatric surgery according to IFSO - APC guidelines * No evidence (objective and subjective) of GERD

Exclusion criteria

* Presence of GERD either by history or by 24 hr pH study

Design outcomes

Primary

MeasureTime frameDescription
GERD6 monthsSubjective (Gastroesophageal Reflux Disease questionnaires - GERD - Q) and objective (24 hour pH study) measurement of occurence of GERD will be done GERD - Q - Score 0-2 denotes no GERD. Score more than or equal to 3 indicates presence of GERD 24 hr pH study - Demeester score more than 14.7 is indicative of presence of GERD

Contacts

Primary ContactPRAKHAR GUPTA
mailto.guptaprakhar@gmail.com+919582438389

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026